5 Best Immunology Stocks to Invest In

Page 1 of 5

In this article, we discuss the 5 best immunology stocks to invest in. If you want to read about some more immunology stocks, go directly to 10 Best Immunology Stocks to Invest In.

5. Xencor, Inc. (NASDAQ:XNCR)

Number of Hedge Fund Holders: 16    

Xencor, Inc. (NASDAQ:XNCR) is a clinical-stage biopharmaceutical company that focuses on the discovery and development of engineered monoclonal antibodies and cytokine therapeutics to treat patients with cancer and autoimmune diseases. On November 10, Xencor announced its presentation of data from the first patients in the Phase 2 combination study of vudalimab, a selective PD-1 x CTLA-4 XmAb bispecific antibody, in patients with metastatic castration-resistant prostate cancer at the 37th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) in Boston.

On December 6, Cowen analyst Boris Peaker initiated coverage of Xencor, Inc. (NASDAQ:XNCR) stock with an Outperform rating without a price target, noting that the company’s partnered programs have the potential to generate revenue of up to $3 billion over the next decade based on milestone and royalty payments.

Among the hedge funds being tracked by Insider Monkey, San Francisco-based investment firm EcoR1 Capital is a leading shareholder in Xencor, Inc. (NASDAQ:XNCR) with 5.3 million shares worth more than $137 million. 

Page 1 of 5